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CAbstract—This study determines the performance of virtual touch imaging quantification (VTIQ), a non-invasive
shear wave elastography method for measuring thyroid nodule (TN) stiffness, in distinguishing benign from ma-
lignant TNs. This prospective study evaluates 707 TNs in 676 patients with fine-needle aspiration biopsy (FNAB).
Before FNAB, both conventional B-mode ultrasound and shear wave elastographywere performed. Surgical resec-
tion was recommended for FNAB results that were not clearly benign. Surgical pathology confirmed 82 malignant
TNs. The receiver operating curve identified a single cut-off of 3.54m/s as themaximum shear wave velocity (SWV)
for predicting thyroid cancer (TC). The sensitivity and specificity were 79.27% and 71.52%, respectively. Positive
predictive value (PPV) was 26.75% and negative predictive value (NPV) was 96.34%. Compared with B-mode US
features for predicting malignancy, SWV$3.54 m/s has a higher sensitivity, specificity, PPVand NPV. TN stiffness
measured by VTIQ-generated shear wave elastography is an independent predictor of TC. (E-mail: azizi@
wilmingtonendo.com)  2015 The Authors. Published by Elsevier Inc. on behalf of World Federation for
Ultrasound in Medicine & Biology. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
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Fine-needle aspiration biopsy (FNAB) is presently
the standard procedure to distinguish between malignant
and benign thyroid nodules (TNs). Approximately 5%–
15% of TNs are malignant (Cooper et al. 2009). Ultra-
sound (US) imaging is an important modality in
diagnosing many head and neck malignancies. B-mode
imaging provides excellent visualization of TNs. Howev-
er, it has a low sensitivity for predicting thyroid cancer
(TC) and it provides limited information about the
mechanical properties of benign and malignant TNs
(Gharib et al. 2010). Prospective TN studies have demon-
strated that adding elastography to B-mode imaging can
improve sensitivity of US technology for detecting TC
(Azizi et al. 2013; Trimboli et al. 2012).ddress correspondence to: Ghobad Azizi, Wilmington Endocri-
, 1717 Shipyard Boulevard, Suite 220, Wilmington, NC 28403,
-mail: azizi@wilmingtonendo.com
onflicts of Interest: No competing financial interests exist.
2855Strain and shear wave elastography investigate dif-
ferences in the mechanical properties of structures by
applying an external force and monitoring the deforma-
tion response. Low relative displacement is linked to
decreased elasticity and malignant findings (Ianculescu
et al. 2014; Krouskop et al. 1998).
Strain elastography requires manual compression by
the operator. In our previously published study, we re-
ported that tissue stiffnessmeasured by strain elastography
is an independent predictor of TC (Azizi et al. 2013).
Several studies showed that this technology can play an
important role in TN selection and risk assessment for ma-
lignancy before FNAB (Bhatia et al. 2011; Friedrich-Rust
et al. 2013; Magri et al. 2013; Rivo-Vazquez et al. 2013).
Strain elastography technology can only produce
semi-quantitative images; it is not capable of precisely
measuring velocity. A color scale is used to assess tissue
stiffness, with each color representing a different level of
tissue stiffness. In addition, there are several different
color map classifications for TN assessment (Asteria
et al. 2008; Azizi et al. 2013; Trimboli et al. 2012).
2856 Ultrasound in Medicine and Biology Volume 41, Number 11, 2015Shear wave elastography is a newer technology with
fewer publications compared to strain elastography.
Nightingale et al. (2003) reported the first administration
of in vivo and ex vivo shear wave generation from acoustic
radiation force. There are several publications about
shear wave elastography and TNs with Supersonic Ima-
gine (SSI) ultrasound with promising results (Sebag
et al. 2010; Slapa et al. 2012; Veyrieres et al. 2012).
Virtual Touch Quantification (VTQ) is a first-
generation acoustic radiation force impulse (ARFI)-
generated shear wave quantification technology.
Although it provides quantitative data, it does not provide
a stiffness map of the TN so that the region of greatest in-
terest can be selected for quantitative measurement.
Several recent publications showed that VTQ was useful
in differentiating between benign and malignant TNs (Xu
et al. 2014; Zhang & Han 2013). VTQ is point shear wave
elastography. More recently available is a 2-D-shear
wave technology generated by ARFI and referred to as
Virtual Touch Imaging Quantification (VTIQ). VTIQ is
capable of creating shear wave image and subsequent tis-
sue quantification in one display and allows for identifica-
tion of regions for measurement of tissue stiffness
(Benson & Fan 2012). The use of VTIQ software in the
United States was approved by the U.S. Food and Drug
Administration (FDA) in June 2013 (Bell 2013).OBJECTIVE
The objective of this study was to prospectively
determine the performance of shear wave elastography
with VTIQ, alone and in conjunction with other
B-mode characteristics, to assess the risk of TC in all
TNs requiring FNAB, not just those preselected for surgi-
cal resection.Principle of acoustic radiation force impulse (ARFI)
elastography
VTIQ is founded on the principle of ARFI technol-
ogy (Benson & Fan 2012). Tissue is compressed using an
acoustic push beam. The push beam is focused at the re-
gion of interest (ROI) to maximize the local displacement
of tissue via the acoustic impulse. This technology is able
to induce and track the propagation of transverse shear
waves for quantification of tissue stiffness. Increased tis-
sue stiffness correlates with increased shear wave veloc-
ity (SWV). The more elastic a given tissue element is, the
more displacement it experiences and the lower the SWV
(Benson & Fan 2012; D’Onofrio et al. 2010; Gallotti et al.
2010; Zhang et al. 2012). In most biological tissues,
shear waves travel at a velocity of 1–10 meters per
second (m/s), which can be measured with VTIQ.
Using image-based localization and proprietary imple-
mentation of ARFI technology, the shear wave speedmay be quantified in a precise anatomic region focused
on a ROI with a predefined 1.5-mm size provided by
the system (Sporea et al. 2011).
The VTIQ image is a color-coded display of shear
wave velocities within the user-defined ROI superim-
posed onto a conventional B-mode ultrasound image.
While VTIQ imaging is quantitative based on SWV
values, the 2-D display provides visualization of the stiff-
ness heterogeneity of the thyroid and TNs with good
spatial resolution. This allows selection of the optimal
measurement locations for highest SWV. VTIQ is
capable of four discrete shear wave display maps: veloc-
ity, quality, travel time and displacement (Benson & Fan
2012). We utilized a blue/red shear wave velocity color
map. The quality map is particularly important to make
sure that the VTIQ image quality is appropriate. Travel
time and displacement maps were not assessed in this
study. Figure 1 shows an example of a TN with VTIQ-
generated shear wave elastography image, velocity mea-
surement and quality map.METHODS
In this study, 694 patients with 725 TNs were evalu-
ated. Among those, 18 patients with 18 TNs were
excluded in the statistical analysis for one or more of
the following reasons: patient moved away, patient
refused recommended surgery or patient did not return
for follow-up. All patients were evaluated by a single
endocrinologist with more than 15 y experience in thy-
roid US. The HIPAA-compliant study protocol was
approved by the Institutional Review Board. For this pro-
spective study, VTIQ was used with IRB approval before
and after FDA clearance.
The inclusion criteria were the presence of a single
or multiple TNs greater than 0.5 cm and age 18 y or older.
All TNs had a diameter of $1.0 cm or a diameter of
$0.5 cm plus at least one of the following ultrasound fea-
tures suspicious for malignant involvement: micro-
calcifications, irregular margins or hypo-echoic pattern.
All patients gavewritten informed consent. The exclusion
criteria were non-diagnostic or abnormal FNAB in pa-
tients who refused repeat FNAB, refused recommended
surgery or did not return for follow-up.
At the time of initial US exam, the following factors
were ascertained in all study patients: gender, age and
number of US-determined TNs. B-mode characteristics
were examined with 18L6 High Definition (HD) probe.
The thyroid gland was evaluated for heterogeneity and
the TNs were evaluated for the following B-mode US
characteristics: size, subcapsular location, isthmus loca-
tion, macro-calcification, micro-calcifications, color
Doppler, power Doppler, solid, iso-echoic, hypo-echoic,
hyper-echoic, tall and complex TN. Micro-calcification
Fig. 1. Solid TNwith shear wave imagewith VTIQ. (a) B-mode image of a solid TNwith the elastography box around the
nodule. (b) Shear wave image of a TN. (c) Shear wave image with tissue quantification of the same TN. The SWV mea-
surement of TNs was 2.34 m/s and 2.6 m/s. Tissue velocity was 3.03 m/s. (d) quality image; green color represents a good
image quality. Fine-needle aspiration biopsy for this TN was benign. SWV5 shear wave velocity; TN5 thyroid nodule;
VTIQ 5 Virtual Touch Imaging Quantification.
Thyroid nodules and shear wave elastography d G. AZIZI et al. 2857was defined as tiny (#1 mm) fleck(s) of calcium inside
the TN without shadowing. Macro-calcification was
defined as dense calcification(s) (.1 mm) that create
acoustic shadowing distally. The TNs were divided into
four groups based on their Doppler vascular patterns:
Group 1 had no blood flow, Group 2 had peripheral blood
flow only, Group 3 had peripheral and central blood flow
(peripheral . central) and group 4 had primarily central
blood flow (central. peripheral). The complex TNs were
divided into four groups: Group 1 had,25% solid tissue,
group 2 had 25%–50% solid tissue, group 3 had 51%–
75% solid tissue and group 4 had .75% solid tissue.
Sub-capsular location was assigned to lesions less than
2 mm from the thyroid capsule. In addition, serum
TSH, free T4, free T3, thyroid peroxidase antibody,
thyroglobulin antibody, thyroglobulin and calcitonin
were measured in all patients before FNAB.
Shear wave elastography
Shear wave elastography was performed using Vir-
tual Touch IQ Software (VTIQ) on the Siemens ACU-
SON S3000 US system with a 9 L4 Multi-D probe
(SIEMENS Medical Solution, Mountain View, CA,
USA). Conventional US exam was performed before
the elastography exam with the same US machine. The
elastography exam was the last part of the US examina-tion before FNAB. Patients were asked not to swallow
or breathe for a few seconds while the shear wave image
was created. The SWV map was acquired twice. SWV
measurement was performed subsequently. Tissue veloc-
ity was measured with a small ROI box measuring
1.5 mm in diameter (ROI box size with VTIQ is predeter-
mined and cannot be changed). The SWV of the stiffest
area within the nodule was measured twice (velocity
Read 1 and 2) and the velocity of the thyroid tissue sur-
rounding the nodule (tissue velocity) was measured
once to assess the difference. The highest velocity of
Read 1 and Read 2 within the nodule was reported as
the maximum SWV. Velocity mean was defined as the
average of the two nodule velocity measurements.
SWV was measured twice within the TN because the
ROI box is relatively small (1.5 mm in diameter).
FNAB procedure
Before the FNAB, we obtained written informed
consent for the procedure. The FNAB was performed un-
der sterile conditions with US guidance to confirm accu-
rate needle placement. Three passes were made of each
lesion using 27-gauge needles. If there was no sample
on visual inspection, a larger needle (25-gauge) was
then used. The samples were submitted for cytologic
evaluation in accordance with the Bethesda system for
2858 Ultrasound in Medicine and Biology Volume 41, Number 11, 2015reporting thyroid cytopathology, resulting in diagnostic
Bethesda categories (BC) I (non-diagnostic or unsatisfac-
tory), II (benign), III (atypia of undetermined significance
or follicular lesion of undetermined significance), IV
(follicular neoplasm or suspicious for follicular
neoplasm), V (suspicious for malignancy) or VI (malig-
nant; Cibas & Ali 2009). For patients with BC I cytology,
a second FNAB was offered.
FNAB results
Figure 2 summarizes the FNAB cytopathology re-
sults in the 707 TNs in 676 patients. Of the 18 TNs
excluded, five were BC I, seven were BC III, four were
BC IV, one was BC Vand one was BC VI. Of the remain-
ing TNs, 562 TNs were BC II, 52 TNs were BC III,
39 TNs were BC IV, 17 TNs were BC V and 32 TNs
were BC VI. Among patients with BC I, five underwent
surgical resection and were included in the statistical
analysis.
Selection for thyroidectomy
Surgical resection was recommended for patients
with FNAB results that were positive for malignancy or
highly suspicious for papillary thyroid carcinoma (PC),
follicular neoplasm or follicular lesion of undetermined
significance using the Bethesda categories. In addition,
thyroid surgery was also recommended for patients
with two non-diagnostic or benign FNABs with two or
more B-mode US features suggestive of TC (irregular
margins, micro-calcifications, hypo-echoic pattern) or
increased size of at least 20% in any 2-D B-mode
dimension.Fig. 2. Summary of fine-needle aspiration biopsy cytopatholog
excluded, 707 TNs in 676 patients were included, 132 patient
TC 5 thyroid cancer; TNSurgical pathology
A total of 132 patients had thyroid surgery. On final
surgical pathology, 82 malignant TNs were confirmed in
76 patients. Of these, 55 were PC, 15 were follicular
variant of PC (FVPC) and 12 were follicular carcinoma
(FC). Thyroid surgery was recommended for 18 patients
with benign FNAB but with two or more worrisome
B-mode US features. Five patients (28%) had TC: two
had FC, two had FVPC and one had PC. There were 10
follicular adenomas among surgical cases, of which seven
had FNAB BC IV and three had BC III. For each patient
undergoing thyroidectomy, we correlated the surgical pa-
thology with the FNAB result and ultrasound. We
compared TN location (left, right, isthmus and distance
from capsule), size and needle tract. All TC on surgical
pathology correlated with the TN evaluated by US and
FNAB. If the TN under investigation did not correlate
with a TC on surgical pathology, then this was considered
an incidental TC and not included as a TC in the statistical
analysis.
See Figure 3 for an example of a solid TN with shear
wave image and subsequent FNAB diagnostic for PC;
surgical pathology confirmed diagnosis.Statistical analysis
Summary statistics, means and standard deviations
for continuous variables, as well as counts and percent-
ages for discrete variables, were used to describe the clin-
ical and demographic characteristics of this sample.
Bivariate associations of presence or absence of TC
with key continuous variables and discrete variables
were determined using Wilcoxon signed tests andy and surgical results. Eighteen TNs in 18 patients were
s had surgery and 82 thyroid carcinomas were analyzed.
5 thyroid nodule.
Fig. 3. Solid TN. (a) Example of a solid TN in the right thyroid lobe, upper pole. (b) Shear wave image with TN. SWV
measurements of TN were 4.74 m/s and 4.75 m/s and for thyroid tissue SWVwas 2.24 m/s. FNAB of this TN was consis-
tent with PC. Surgical pathology confirmed the diagnosis of PC. TN 5 thyroid nodule; SWV 5 shear wave velocity;
PC 5 papillary carcinoma; FNAB 5 fine-needle aspiration biopsy.
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sion was used to examine the maximum and mean SWV
as continuous variables. Using backward stepwise vari-
able selection procedure, multivariate logistic regression
was used to determine the association of presence of TC
with SWV (as discrete variable) along with other key var-
iables age, gender, heterogeneous gland, hypo-echoic
TN, hyper-echoic TN, isthmus location, micro-
calcifications, irregular margins, tall, sub-capsular loca-
tion, color and power Doppler. The receiver operating
characteristic (ROC) curve was used to examine the
sensitivity and specificity and negative and positive pre-
dictive values of SWV predicting TC. This also enabled
the validation of the SWV cut-offs that were pre-
determined from clinical experience with the cut-offs
generated from the ROC curve. Statistical significance
was determined at alpha of 0.05. All statistical analysis
was conducted in SAS 9.3 (SAS Institute, Cary, NC,
USA).
RESULTS
Statistical analysis was conducted on 707 TNs in
676 patients with a mean age of 51.2 y (SD5 15.0; range
18 to 92 y). Most of the TNs (85.7%; N 5 606) were
found in women. A total of 82 TNs (11.6%) were diag-
nosed as TC.
Bivariate analysis
The bivariate associations of cancer status with de-
mographic, clinical variables and ultrasound (B-mode
and elastography) characteristics are presented in Table 1.
The maximum SWV for the malignant TN was
4.27 6 1.07 m/s, which was significantly greater than
the maximum SWVof the benign TN (3.23 6 0.83 m/s;
p , 0.0001). Similar findings were obtained for other
measurements of nodule elasticity. The mean SWV of
the stiffest areas of the TC was significantly higher versusthe benign TN (4.13 6 1.03 m/s vs. 3.1 6 0.78 m/s;
p, 0.0001). There was no significant difference between
velocity Read 1 and Read 2 of the stiffest area. There was
no statistical difference in the velocity of the tissue sur-
rounding the TN in cancer versus non-cancer group.
Amongst the demographic characteristics, those pa-
tients with TC were significantly younger (mean 6 SD;
42.93 6 12.88 y) than those patients without cancer
(52.29 6 14.96 y; p , 0.0001). There was no significant
association of gender with TC.
Amongst the B-mode ultrasound characteristics, a
heterogeneous thyroid gland was more prevalent among
the cancer group with 81.71% versus 68.32% in the
non-cancer group (p 5 0.0130). Other B-mode ultra-
sound characteristics that showed a statistical difference
included: macro-calcifications and micro-calcifications
combined: non-cancer group versus cancer group
(39 TN [6.24%] versus 12 TN [14.63%; p 5 0.0057]);
micro-calcifications alone: non-cancer group versus can-
cer group (186 TN [29.76%] versus 48 TN [58.54%;
p , 0.0001]); sub-capsular location: non-cancer group
versus cancer group (416 TN [66.56%] versus 64 TN
[78.05%; p 5 0.0362]); and hypo-echoic TN: non-
cancer group versus cancer group (199 TN [31.84%]
versus 35 TN [42.68%; p 5 0.0498]). In contrast, for
TN with macro-calcification only, there was no statistical
difference among cancer versus non-cancer TNs.
There was no significant difference in cancer versus
non-cancer for the following characteristics: isthmus
location, complex TN, solid, iso-echoic, hyper-echoic,
tall TN or any color or power Doppler group.Receiver operating curves of continuous maximum SWV
predicting TC
The ROC curvewas used to determine the sensitivity
and specificity of the continuous variable of maximum
SWV to predict TC (Fig. 4). The area under the curve
Table 1. The bivariate associations of cancer status with demographic, clinical variables and ultrasound characteristics
Variable No cancer n (%)/Mean (SD) (N 5 625) Cancer n (%)/Mean (SD) (N 5 82) p value
Age 52.29 (14.96) 42.93 (12.88) ,0.0001
TN Velocity Read 1 3.11 (0.8) 4.17 (1.02) ,0.0001
TN Velocity Read 2 3.1 (0.81) 4.1 (1.07) ,0.0001
Velocity Tissue Surrounding TN 2.69 (0.4) 2.66 (0.52) 0.9281
Maximum SWV 3.23 (0.83) 4.27 (1.07) ,0.0001
Mean SWV 3.1 (0.78) 4.13 (1.03) ,0.0001
Complex TN 189 (30.24) 13 (15.85) 0.0067
Female 536 (85.76) 70 (85.37) 0.9236
Heterogeneous Gland 427 (68.32) 67 (81.71) 0.0130
Hyper-echoic TN 8 (1.28) 0 (0) 0.3028
Hypo-echoic TN 199 (31.84) 35 (42.68) 0.0498
Irregular Margins 243 (38.88) 60 (73.17) ,0.0001
Iso-echoic TN 415 (66.4) 47 (57.32) 0.1041
Isthmus Location 33 (5.28) 5 (6.1) 0.7576
Macro- & Micro-calcifications 39 (6.24) 12 (14.63) 0.0057
Macro-calcification 85 (13.6) 17 (20.73) 0.0840
Micro-calcifications 186 (29.76) 48 (58.54) ,0.0001
C1 276 (44.16) 37 (45.12) 0.8690
C2 192 (30.72) 24 (29.27) 0.7884
C3 118 (18.88) 12 (14.63) 0.3507
C4 39 (6.24) 9 (10.98) 0.1090
P1 276 (44.16) 37 (45.12) 0.8690
P2 192 (30.72) 24 (29.27) 0.7884
P3 116 (18.56) 12 (14.63) 0.3854
P4 41 (6.56) 9 (10.98) 0.1425
Solid TN 425 (68) 68 (82.93) 0.0057
Sub-capsular Location 416 (66.56) 64 (78.05) 0.0362
Tall TN 23 (3.68) 3 (3.66) 0.9923
TN 5 thyroid nodule; SWV 5 shear wave velocity.
2860 Ultrasound in Medicine and Biology Volume 41, Number 11, 2015for this model is 0.78, which is moderately high. Based on
the ROC curve SWV predicting cancer, a single cut-off of
3.54 m/s has of sensitivity and specificity of 79.27% and
71.52%, respectively; positive predictive value (PPV)
was 26.75% and negative predictive value (NPV) was
96.34%.Fig. 4. Receiver operating characteristic using malignant
nodule 5 1 to be the positive level.The unadjusted association of categorized maximum
SWV with TC
Based on previous clinical experience, maximum
SWV was divided into five groups: reference group
(0–2.5 m/s), group 1 (.2.5–3.2 m/s), group 2 (.3.2–
3.8 m/s), group 3 (.3.8–4.5 m/s) and group 4 (.4.5 m/
s). Using the 0–2.5 m/s category as the reference, this var-
iable of categorized SWV was used to predict TC. Odds
of predicting TC compared to the reference group pro-
gressively increased with higher SWV categories except
for .2.5–3.2 m/s velocity (group 2 [OR: (95% CI)
4.492 (1.246, 16.197)], group 3 [OR: (95% CI) 9.733
(2.831, 33.455)] and group 4 [OR: (95% CI) 24.104
(7.050, 82.407)]; Table 2). In addition, mean velocity
and maximum velocity (not shown in tables) are also pre-
dictors of TC.
Prevalence of benign & malignant TNs categorized by
maximum SWV groups predicting TC
The reference group (SWV 0–2.5 m/s) had 114
benign TNs (97.44%) and 3 malignant TNs (2.56%).
Group 1 had 263 benign TNs (95.99%) and 11 malignant
TNs (4.01%). Group 2 had 109 benign TNs (89.34%) and
13 malignant TNs (10.66%). Group 3 had 89 benign TNs
(79.46%) and 23 malignant TNs (20.54%). Group 4 had
50 benign TNs (60.98%) and 32 malignant TNs
(39.02%). These findings are summarized in Figure 5.
Table 2. Logistic model: Maximum SWV in pre-determined groups predicting malignancy for each SWV group. The FREQ
Procedure
Table of malignant nodule by velocity reference
Velocity Max reference (m/s)
Reference 1 2 3 4
Velocity Max group 0–2.5 .2.5–3.2 .3.2–3.8 .3.8–4.5 .4.5 Total
Benign TN (%) 114 (97.44) 263 (95.99) 109 (89.34) 89 (79.46) 50 (60.98) 625 (88.39)
Cancer TN (%) 3 (2.56) 11 (4.01) 13 (10.66) 23 (20.54) 32 (39.02) 82 (11.61)
Total TN 117 274 122 112 82 707
TN 5 thyroid nodule; SWV 5 shear wave velocity.
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A multivariate regression model with variables se-
lection via the backward selection process was devel-
oped to determine which variables were independent
predictors of TC. The model included the above cate-
gories of SWV adjusted for the variables age, gender,
heterogeneous thyroid gland, hypo-echoic TN, hyper-
echoic TN, isthmus location, micro-calcifications, tall
TN, sub-capsular location, irregular margins, color
and power Doppler (Table 3). Compared to the refer-
ence group of 0–2.5 m/s, the SWV group 3 (.3.8–
4.5 m/s; OR: [95% CI] 6.250 [1.769, 22.076]) and
group 4 (.4.5 m/s; OR: [95% CI] 11.593 [3.254,
41.305]) have significantly higher risk for TC. Presence
of micro-calcifications (OR: [95% CI] 2.018 [1.185,
3.436]), irregular margins (OR: [95% CI] 2.685
[1.528, 4.719]) and younger age group (,45 y; OR:Fig. 5. Number of TNs and prevalence percentage of malignan
noma among TNs in the study, stratified by SWV group. The c
and the line represents the percentage of malignancies for eac
wave velo[95% CI] 0.316 [0.185, 0.537]) were predictive of
cancer.
Sensitivity, specificity, and positive and negative
predictive values
Table 4 shows the sensitivity, specificity, positive
predictive value (PPV) and negative predictive value
(NPV) for each respective SWV group and B-mode
characteristics predicting cancer (micro-calcifications
and irregular margins). Group 4, with SWV .4.5 m/s,
had the following sensitivity, specificity, PPV and
NPV: 39.02%, 92%, 39.02% and 92%. For micro-
calcification, sensitivity was 58.54% and specificity,
PPV and NPV were 70.24%, 20.51% and 92.81%,
respectively. For irregular margins, sensitivity, speci-
ficity, PPV and NPV were 73.17%, 61.12%, 19.8%
and 94.55%, respectively. TNs with SWV of $3.54cy in each SWV group. The prevalence of thyroid carci-
olumns represent the total number of TNs for each group
h respective group. TN 5 thyroid nodule; SWV 5 shear
city.
Table 3. Multivariate logistic model: Predictors of thyroid cancer
Effect Odds ratio 95% Lower confidence 95% Upper confidence
Age Group (.45 y) vs. reference: #45 y 0.316 0.185 0.537
Velocity: .2.5– 3.2 vs. reference: 0–2.5 1.116 0.299 4.165
Velocity: .3.2–3.8 vs. reference: 0–2.5 2.595 0.695 9.689
Velocity: .3.8–4.5 vs. reference: 0–2.5 6.250 1.769 22.076
Velocity: .4.5 vs. reference: 0–2.5 11.593 3.254 41.305
Micro-calcifications vs. reference 2.018 1.185 3.436
Irregular Margins vs. reference 2.685 1.528 4.719
2862 Ultrasound in Medicine and Biology Volume 41, Number 11, 2015had the highest sensitivity, specificity, PPV and NPV
(79.27%, 71.52%, 26.75% and 96.34%, respectively)
compared with micro-calcifications and irregular mar-
gins. Among TNs with SWV of $3.54, there were 65
malignant TNs and 178 benign TNs.Maximum shear wave velocity of TC groups (PC, FVPC
and FC)
In this sub-group analysis of the cancer types, we had
82 TC with 55 PC, 15 FVPC and 12 FC. The mean of
maximum SWV for PC was 4.39 6 1.13 m/s, for FVPC
was 4.18 6 0.75 m/s and for FC was 3.85 6 1.04 m/s.
There was no statistical difference between maximum
SWVs. FC is an underpowered subset analysis, so any con-
clusions should be accepted cautiously.Additional analysis per patient
In a separate statistical analysis we included only
one TN per patient, for 676 TNs in 676 patients. Only
4% of patients in this study had more than one TN exam-
ined. When we included only one TN per patient, the sta-
tistical results were very similar with per TN analysis, i.e.,
707 TNs in 676 patients.DISCUSSION
The objective of this prospective study was to eval-
uate the performance of VTIQ-generated SWV of unse-
lected TNs to predict TC risk. VTIQ is capable ofTable 4. Sensitivity, specificity and positive and negative pred
maximum SWV and B-m
Value of maximum velocity (m/s) Sensitivity Sp
0–2.5 vs. rest 3/82 5 3.66% 512/62
.2.5–3.2 vs. rest 11/82 5 13.41% 362/62
.3.2–3.8 vs. rest 13/82 5 15.85% 516/62
.3.8–4.5 vs. rest 23/82 5 28.05% 536/62
.4.5 32/82 5 39.02% 575/62
$3.54 vs. ,3.54 65/82 5 79.27% 447/62
B-mode Characteristics
Irregular Margins 60/82 5 73.17% 382/62
Micro-calcifications 48/82 5 58.54% 439/62
SWV 5 shear wave velocity.creating shear wave imaging and subsequent tissue quan-
tification in one display.
In our study, maximum SWVof malignant TNs was
mostly higher than that of surrounding thyroid tissue and
benign TN. Our single cut-off maximum SWV for pre-
dicting TC, based on the ROC curve, was 3.54 m/s with
sensitivity and specificity of 79.27% and 71.52%, respec-
tively; PPV was 26.75% and NPV was 96.34%. The per-
formance of SWV was compared with that of other
clinical and B-mode ultrasound characteristics. In the
multi-regression analysis, the maximum SWV was the
strongest predictor of malignancy, surpassing the other
statistically significant predictors: younger age, micro-
calcifications and irregular margins. VTIQ may help pre-
dict the malignant potential of a TN and may help in
nodule selection for FNAB.
In our second analysis, we divided TNs into five
different predetermined groups based on SWV. In the
reference group, which had the lowest SWV value (0–
2.5 m/s), the rate for TC was 2.56% and for benign TN
was 97.44%. For group 4, which had highest SWV value
(.4.5 m/s; OR: [95% CI] 11.593 [3.254, 41.305]), the
rate for TC was 39.02% and for benign TN was 60.98%.
For group 4, sensitivity, specificity, PPV and NPV were
39.02%, 92%, 39.02% and 92%, respectively. These clin-
ically predetermined groups correlated well with the ROC
determined cut-off of 3.54 m/s.
More data are needed to establish a single or multi-







5 5 81.92% 3/116 5 2.59% 512/591 5 86.63%
5 5 57.92% 11/274 5 4.01% 362/433 5 83.60%
5 5 82.56% 13/122 5 10.66% 516/585 5 88.21%
5 5 85.76% 23/112 5 20.54% 536/595 5 90.08%
5 5 92% 32/82 5 39.02% 575/625 5 92%
5 5 71.52% 65/243 5 26.75% 447/464 5 96.34%
5 5 61.12% 60/303 5 19.8% 382/404 5 94.55%
5 5 70.24% 48/234 5 20.51% 439/473 5 92.81%
Fig. 6. Complex, partially malignant TN. (a) Complex TN, measuring 22 mm. (b) Shear wave image of the TN. SWV
measurements of TN were 5.93 m/s and 5.15 m/s and for thyroid tissue SWVwas 2.77 m/s. Fine-needle aspiration biopsy
was read atypia of undetermined significance (BC III). This patient had a positive BRAF mutation. Surgery was recom-
mended and surgical pathology showed an 11-mm papillary carcinoma. This lesion was partially malignant. TN5 thyroid
nodule; SWV 5 shear wave velocity.
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grade the risk for malignancy in conjunction with B-
mode imaging is already being used in breast lesions
and BIRAD classification. This could be duplicated for
TNs with abnormal FNAB, BC III and BC IV.Soft thyroid nodule (SWV #2.5 m/s)
Soft TN refers to lesions with SWV of 2.5 m/s or
less. The rate of malignancy for this group of TN was
2.56%. These TNs are considered as low risk for TC.Hard thyroid nodule (SWV $3.54 m/s)
Hard TN refers to lesions with SWVof 3.54 m/s or
higher. In this study, the rate of TC was 26.75%. This
group can be divided to additional sub-groups. The risk
for TC is the highest for TN with SWV of 4.5 m/s or
higher.Intermediate thyroid nodule (SWV .2.5–,3.54 m/s)
Intermediate TN refers to lesions with SWV be-
tween 2.5 and 3.54 m/s. The rate of TC was 4.1%
(moderate).Potential future use of VTIQ
Recent publications in the New England Journal of
Medicine and Thyroid Journal examined TNs with
FNAB of atypia of undetermined significance
(Alexander et al. 2012; Hodak & Rosenthal 2013).
They reported that using commercially available
molecular diagnosis testing improved pre-operative risk
assessment for TC, but it does not provide any help in
nodule selection and false-negative FNAB. In our experi-
ence, adding shear wave elastography has the potential to
improve our ability for risk assessment of TNs with low
risk or very high risk, including BC III and IV. Figure 6
is an example of a complex TN with an abnormalVTIQ image; FNAB was read as BC III, with a subse-
quent positive BRAF mutation, and surgical pathology
revealed an 11 mm PC in a 22 mm TN.
In this study PC and FVPC had higher maximum
SWV compared with FC, but did not reach statistical sig-
nificance. Perhaps a larger study is needed to evaluate the
ability of SWV in TC-subtype differentiation. In a recent
Radiology publication, Samir et al. (2015) also demon-
strates the potential benefit of SWV in TNs with atypical
FNAB (BC III or BC IV) in a pilot study of 35 patients.
Finally, strain and shear wave elastography can be
used separately or combined in assessing TN stiffness.Limitations of VTIQ
The following may cause false SWV value
measurement:
1. Location of TN deeper than 4 cm and/or isthmus
location.
2. TNwith calcified content (.25%). In our study, macro-
calcification, and to a lesser extent micro-calcifications,
were associated with high SWV and benign FNAB.
Among TNs with SWV $3.54 m/s and benign
FNAB, 55 nodules (30%) had macro-calcification and
29 TN (15.4%) had micro-calcifications.
3. Complex TN with high fluid content (.50%). In fluid,
pressure is the same in all directions; therefore shear
waves do not exist in fluids (Benson & Fan 2012).
SWV may be measurable in fluid with debris or
viscous content. In TN with fluid content of .50%,
we suggest using a smaller ROI box to avoid the cystic
component of a TN.
4. Severe Hashimoto’s thyroiditis and tissue fibrosis of
thyroid gland due to chronic lymphocytic thyroiditis.
It is important to note that the majority of patients
with benign FNAB did not have surgery for a definitive
2864 Ultrasound in Medicine and Biology Volume 41, Number 11, 2015diagnosis. It is possible that some of these lesions may be
malignant despite benign biopsy. In general it is reported
that the risk of TC following a benign biopsy is less than
3% (Cibas & Ali 2009). Therefore, it is unlikely that
false-negative FNAB would significantly affect the re-
sults and conclusions. This is a limitation for almost all
studies of unselected TNs. Furthermore, the prevalence
of malignancy for TNs was 11.5%. This is within the ex-
pected range and indicates that the false-negative rate of
FNAB was not unusually high.
Thyroid surgery was even recommended for 18 pa-
tients with benign FNAB but with two or more worrisome
US features. Of those 18, five were malignant TN with
benign FNAB: two FC, two FVPC and one PC.
Among conventional US features, micro-
calcifications and irregular margins were also predictors
for TC, but significantly weaker than shear wave elastog-
raphy. This result is in line with our previous publication.
When we compare our strain elastography study with our
present study, VTIQ appears to have a higher specificity
and PPV (Azizi et al. 2013).
Comparison with other shear wave studies/technologies
Other studies have evaluated the performance of
shear wave elastography. Two such studies that used
SSI technology were proof-of-concept studies that
included a relatively small number of patients who
were a sub-group that had been pre-selected for surgery
(Sebag et al. 2010; Veyrieres et al. 2012). There were
only 29 TC in one study (Sebag et al. 2010) and 35 TC
in the other (Veyrieres et al. 2012). These two studies
differed in the methods used to account for the intra-
nodular stiffness heterogeneity. In one, the measurement
was made in the stiffest part of the nodule (Veyrieres et al.
2012), while the other (Sebag et al. 2010) did not specify
how they dealt with the confounding factor. The studies
employed SSI technology report stiffness in kPa, so the
calculated cut-off values are not directly comparable to
our results expressed in m/s. By evaluating a large num-
ber of benign and malignant TNs in a single study, we
were able to obtain greater statistical power. Furthermore,
since the TNs of our study did not represent a group of
patients pre-selected for surgery, the PPV and NPV are
useful in the evaluation of all TNs meeting the American
Thyroid Association’s (ATA) criteria for FNAB.
In a third study, the ARFI technology was found to
be effective in distinguishing benign from malignant
TNs (Xu et al. 2014). Xu et al. published a prospective
VTQ study that examined 441 TNs in 375 patients with
a 26.3%malignancy rate. The best cut-off for distinguish-
ing benign from malignant TNs was determined to be
2.87 m/s, which is slightly lower than the value of
3.54 m/s that we obtained measuring the stiffest region
of TNs using VTIQ.This discrepancy is likely accounted for by the
region of the TN selected for SWV measurement. The
stiffness of TNs is heterogeneous. The VTIQ technology
superimposes the region selected for SWV measurement
over the VTI image, so the firmest region of each TN can
be assessed. VTQ technology alone does not allow for
this selection; it generates an average elasticity measure-
ment over a greater area (ROI box 63 5 mm). Therefore,
the maximum SWV is expected to be greater for the
VTIQ method used here (ROI box 1.5 3 1.5 mm). In
addition, there is greater probability of variation between
SWV measurements of TNs with heterogeneous stiffness
if VTQ technology is used alone. Finally, Xu et al. per-
formed VTQ analysis in a pre-selected sub-group that
excluded many TNs (732 TN in 625 patients). We did
not pre-select TN; therefore, our PPV and NPV can be
applied to a much larger population of TNs.
Siemens US system only provides SWV measure-
ment in m/s; however, m/s can be converted to kilopascals
(kPa) using the following formula: kPa (Young’s
Modulus) 5 3 pc2, where c is shear wave speed in m/s
and p is tissue density (a constant). For example, a
SWVof 4.5 m/s is 60.75 kPa (Bercoff 2008).Summary
Based on the ROC curve SWV predicting cancer, a
single cut-off at 3.54 m/s has a sensitivity and specificity
of 79.27% and 71.52%, respectively; PPV was 26.75%
and NPV was 96.34%. In multi-group analysis, for the
lowest risk group the SWV was 0–2.5 m/s with 2.59%
prevalence of TC. The highest risk group, with SWV
.4.5 m/s, had a 39% prevalence of TC. TN stiffness
measured by VTIQ-generated shear wave elastography
is an independent predictor of TC. VTIQ is not here to
replace B-mode ultrasound. Shear wave elastography
can enhance the B-mode findings and potentially improve
our cancer detection rate and selection of patients for
FNAB. We conclude that VTIQ-generated shear wave
elastography using quantitative assessment of mechani-
cal tissue properties provide a new dimension in TN eval-
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